Back to Results
First PageMeta Content
Lung cancer / Amines / Quinazolines / Alkynes / Erlotinib / Ethers / Epidermal growth factor receptor / Protein kinase inhibitor / Targeted therapy / Chemistry / Organic chemistry / Medicine


Document Date: 2015-03-23 21:11:42

Open Document

File Size: 70,51 KB

Share Result on Facebook

Company

Medical Oncologists Group of Australia / AEs / Roche Products Pty Limited / PBAC / ITT / /

Country

Australia / /

Currency

USD / /

Event

FDA Phase / /

Facility

Consumer Comments facility / National Cancer Institute of Canada Clinical Trials Group Study BR.21 / /

IndustryTerm

therapy for advanced or metastatic disease / /

MedicalCondition

cancer / disease / NSCLC / skin disorders / eye disorders / EGFR mutation positive tumours / subcutaneous tissue disorders / progressive disease / metastatic disease / pain / aggressive disease / EGFR wild type disease / lung cancer / Non-small-cell lung cancer / completed Non-Small Cell Lung Cancer / non-small cell lung cancer / IIIB/IV non-small cell lung cancer / EGFR wild type tumours / cough / EGFR wild-type disease / squamous disease / infections / gastrointestinal disorders / rash / stage disease / nutrition disorders / /

MedicalTreatment

radiation therapy / anticancer therapy / chemotherapy / /

Movie

Quality of life / /

Organization

World Health Organization / PBAC Medical Oncology Advisory Committee / National Cancer Institute of Canada Clinical Trials Group Study BR.21 / /

Person

Erlotinib vs / Max Qty / /

Position

principal investigator / representative / /

Product

Roche Erlotinib Tablet / Manufacturer Erlotinib Tablet / Tarceva / OSI-774 / /

Technology

radiation / Trial ID Protocol title/ Publication title Publication citation BR.21 Protocol / chemotherapy / /

SocialTag